Morrisville, North Carolina, United States In 2013 was created Envisia Therapeutics, which is appeared as Corporate Investor. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Morrisville.
The important activity for fund was in 2014. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Correlation Ventures, Canaan Partners.
The fund was created by Benjamin Yerxa.
Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline LQ3 Pharmaceuticals Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
| Fund Name | Location |
| Boyi Investment Fund | - |
| Calibre Ventures | Central, Central Region, Singapore |
| Five T Investments | - |
| Guggenheim Securities | New York, New York, United States |
| JCEP Investments, LLC | - |
| Lyrical Partners | New York, New York, United States |
| OSF Ventures | Illinois, Peoria, United States |
| State Oil Fund of Azerbaijan (SOFAZ) | Azerbaijan, Baki, Baku |
| Summit Park | Charlotte, North Carolina, United States |
| TIFEC | Delhi, India, New Delhi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
LQ3 Pharmaceuticals | $10M | 10 Sep 2014 | North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
LQ3 Pharmaceuticals | $10M | 10 Sep 2014 | North Carolina, United States |
